4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-056149
President and CEO sold 20,000 shares at $14.76 ($295,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2022-11-07 | Sale | −20,000 | $14.76 | $295,200 | 7,785,820 | D |
| Open-market sales · 20,000 sh · avg $14.76 · $295,200 | |||||||
Loading xslF345X03/doc4.xml…